Log in

AquaBounty Technologies Stock Forecast, Price & News

-0.14 (-3.38 %)
(As of 10/21/2020 12:00 AM ET)
Today's Range
Now: $4.00
50-Day Range
MA: $4.20
52-Week Range
Now: $4.00
Volume418,204 shs
Average Volume396,356 shs
Market Capitalization$128.50 million
P/E RatioN/A
Dividend YieldN/A
AquaBounty Technologies, Inc., a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts. AquaBounty Technologies, Inc. is a subsidiary of Intrexon Corporation.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesN/A



Market Cap$128.50 million
Next Earnings DateN/A
OptionableNot Optionable
-0.14 (-3.38 %)
(As of 10/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AQB News and Ratings via Email

Sign-up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

AquaBounty Technologies (NYSE:AQB) Frequently Asked Questions

How has AquaBounty Technologies' stock price been impacted by Coronavirus?

AquaBounty Technologies' stock was trading at $1.85 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AQB stock has increased by 116.2% and is now trading at $4.00.
View which stocks have been most impacted by COVID-19

How were AquaBounty Technologies' earnings last quarter?

AquaBounty Technologies (NYSE:AQB) issued its quarterly earnings results on Thursday, August, 6th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.11).
View AquaBounty Technologies' earnings history

Who are some of AquaBounty Technologies' key competitors?

What other stocks do shareholders of AquaBounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AquaBounty Technologies investors own include Inovio Pharmaceuticals (INO), Axsome Therapeutics (AXSM), NVIDIA (NVDA), JD.com (JD), Moderna (MRNA), Square (SQ), AbbVie (ABBV), Pfizer (PFE), Cassava Sciences (SAVA) and Abbott Laboratories (ABT).

Who are AquaBounty Technologies' key executives?

AquaBounty Technologies' management team includes the following people:
  • Mr. David A. Frank, CFO & Treasurer (Age 59)
  • Dr. Ronald L. Stotish, Chief Technology Officer (Age 70)
  • Mr. Alejandro Rojas, Chief Operating Officer of Aquabounty Farms (Age 57)
  • Ms. Sylvia Wulf, CEO, Pres & Exec. Director (Age 61)
  • Mr. Christopher H. Martin, Gen. Counsel & Company Sec. (Age 53)

What is AquaBounty Technologies' stock symbol?

AquaBounty Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "AQB."

How do I buy shares of AquaBounty Technologies?

Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AquaBounty Technologies' stock price today?

One share of AQB stock can currently be purchased for approximately $4.00.

How big of a company is AquaBounty Technologies?

AquaBounty Technologies has a market capitalization of $128.50 million. AquaBounty Technologies employs 39 workers across the globe.

What is AquaBounty Technologies' official website?

The official website for AquaBounty Technologies is www.aquabounty.com.

How can I contact AquaBounty Technologies?

The company can be reached via phone at 978-648-6000.

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.